|
|
|
| Study on the medication rule of cough variant asthma from the perspective of wind theory |
| JING Weichao1 LIU Lujia1 WANG Youpeng2 LI Zhijun3 |
1.The Second Clinical Medical College, Heilongjiang University of Chinese Medicine, Heilongjiang Province, Harbin 150040, China;
2.Department of Pediatrics, the Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Heilongjiang Province, Harbin 150001, China;
3.Jixi People′s Hospital Medical Group, Heilongjiang Province, Jixi 158100, China |
|
|
|
Abstract Objective To analyze the prescription medication rule of cough variant asthma (CVA) from the perspective of wind theory. Methods By using computer retrieval, combinated of “cough variant asthma” or “wind cough” and “treatment from wind”, “wind”, “dispelling wind” and “expelling wind”. The literatures about treating CVA from wind theory were retrieved from CNKI, VIP database, and Wanfang data knowledge service platform from January 1979 to July 2019. Then, the data was put into the software of Chinese medicine inheritance assistant platform to analyze the rule of prescription medication. Results The study eventually included 127 articles and 127 prescriptions, including 120 herbal medicine. The herbal medicine′s use and frequency was analyzed, more than 20 times were Periostracum Cicadae, Radix Glycyrrhizae, Semen Armeniacae Amarum, Herba Ephedrae, etc, then the use pattern of prescription was got. Eight core drug combinations and four new candidates were found. Conclusion The prescriptions for CVA treated by wind theory are mostly used for dispersing wind and dissipating heat, dispelling wind and resolving exterior symptoms, clearing away heat and resolving wind, dispersing lung and relieving cough. Emphasis is laid on the compatibility and application of wind medicine with cough-relieving drugs, lung-promoting drugs, blood-activating and collateral-dredging drugs, etc, so as to provide reference for the clinical medication of the patients treated by wind.
|
|
|
|
|
|
[1] Wei H，Li W，Jiang Z，et al. Clinical efficacy of montelukast sodium combined with budesonide or combined with loratadine in treating children with cough variant asthma and influence on inflammatory factors in the serum [J]. Exp Ther Med，2019，18（1）：411-417.
[2] 赖浩，许冠杰，王富英.孟鲁司特钠辅助治疗咳嗽变异性哮喘患儿的效果及对血清炎症因子的影响[J].中国医药科学，2018，8（22）：50-53.
[3] 王宁，霍晓颖，陈葆青，等.苏黄止咳胶囊联合舒利迭对咳嗽变异性哮喘患者血清TNF-α、TGF-β1和IgE水平的影响[J].河北医学，2018，24（5）：718-722.
[4] 薛飞.金敏汤治疗小儿咳嗽变异性哮喘风束肺络证的相关研究[D].南京：南京中医药大学，2019.
[5] Sun W，Liu HY. Montelukast and budesonide for childhood cough variant asthma [J]. J Coll Physicians Surg Pak，2019，29（4）：345-348.
[6] Kanemitsu Y，Niimi A，Matsumoto H，et al. Gastroesophageal dysmotility is associated with the impairment of cough-specific quality of life in patients with cough variant asthma [J]. Allergol Int，2016，65（3）：320-326.
[7] Liu W，Chen H，Zhang D，et al. A retrospective study of clinical features of cough variant asthma in Chinese adults [J]. Allergy Asthma Clin Immunol，2019，15（1）：3.
[8] 庄明凤，马敬斌，殷汝昌，等.孟鲁司特咀嚼片对咳嗽变异性哮喘肺功能的影响[J].临床肺科杂志，2017，22（1）：89-92.
[9] 高龙霞，阎玥，包海鹏，等.咳嗽变异性哮喘现代研究进展[J].中华中医药杂志，2019，34（9）：4171-4174.
[10] 景伟超.抗支糖浆对CVA豚鼠模型Th17/Treg失衡的免疫调节机制研究[D].哈尔滨：黑龙江中医药大学，2018.
[11] 徐超极.基于Th1/Th2失衡机制观察儿童咳嗽变异性哮喘中医分期治疗的临床疗效[D].福州：福建中医药大学，2018.
[12] 王志超，李晶.从风论治咳嗽变异性哮喘[J].世界中西医结合杂志，2018，13（2）：289-291.
[13] 秦胜娟，王成礁，佘继林.佘继林治疗小儿风咳经验[J].吉林中医药，2018，38（10）：1152-1154.
[14] 徐萍利，张俊娜，冯倩，等.中医辨治咳嗽变异性哮喘的研究进展[J].中国中医急症，2014，23（7）：1315-1316.
[15] 吴龙传，田仲成.田仲成从风论治咳嗽变异型哮喘急性发作期经验[J].湖南中医杂志，2019，35（8）：21-22.
[16] 周莹，柏正平.柏正平从“风”论治咳嗽变异型哮喘经验[J].湖南中医杂志，2019，35（7）：21-22.
[17] 国家药典委员会.中华人民共和国药典[M].北京：中国医药科技出版社，2015.
[18] 高学敏.中药学[M].北京：中国中医药出版社，2007.
[19] 施国善，曲婉莹，王有鹏.风药在小儿咳嗽变异性哮喘中的应用探析[J].中国中医急症，2017，26（3）：437-439.
[20] 周伟，樊长征，张文江，等.王书臣从风论治咳嗽变异性哮喘经验[J].环球中医药，2016，9（10）：1252-1253.
[21] 史文丽.“祛风活血、化痰止咳”法治疗儿童咳嗽变异性哮喘肺风证临床及机制研究[D].北京：北京中医药大学，2015.
[22] 杜渊，王蔚，马君蓉.从风痰瘀论治小儿咳嗽变异性哮喘[J].四川中医，2014，32（2）：47-48. |
|
|
|
